Related Experiment Video
Updated: Oct 14, 2025

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Postmenopausal women with hyperandrogenemia: Three case reports.
Xiao-Dan Zhu1, Lin-Yu Zhou1, Jian Jiang1
1Department of Ultrasound Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang Province, China.
Diagnosing ovarian steroid cell tumors in postmenopausal women is challenging due to subtle or absent symptoms. This case series highlights key clinical and imaging features for accurate diagnosis and effective surgical treatment.
Area of Science:
- Endocrinology
- Gynecologic Oncology
- Radiology
Background:
- Diagnosing hyperandrogenemia in postmenopausal women presents significant challenges, often leading to misdiagnosis or delayed detection.
- Ovarian steroid cell tumors are rare, accounting for approximately 0.1% of all ovarian tumors, contributing to a lack of typical imaging findings.
- The subtle or absent clinical manifestations of hyperandrogenemia in postmenopausal women complicate early identification.
Observation:
- Three postmenopausal women with hyperandrogenemia were evaluated, with only one exhibiting virilization symptoms.
- Two patients were asymptomatic, underscoring the often-silent nature of these tumors.
- Histological examination revealed one Leydig cell tumor and two benign, non-specific steroid cell tumors.
Findings:
- Ovarian steroid cell tumors can present asymptomatically, despite elevated serum testosterone levels.
- Typical imaging features include a solid, slightly hypoechoic, round or oval mass with uniform internal echo, prominent vascularity, and a low resistance index.
- Surgical intervention confirmed the diagnosis and effectively treated the condition in all reported cases.
Implications:
- Accurate diagnosis of ovarian steroid cell tumors in postmenopausal women requires a comprehensive approach integrating clinical and imaging data.
- Early detection and surgical management offer a definitive treatment for hyperandrogenemia caused by these rare ovarian neoplasms.
- Further research into characteristic imaging findings can improve the diagnostic accuracy for these uncommon tumors.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
07:37Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
Published on: August 16, 2024
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Disorders of the Female Reproductive System
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation